America Cell Bank

What America Cell Bank does

America Cell Bank is a Colombia-headquartered, private multinational biomedical company specializing in umbilical cord blood and tissue stem cell cryopreservation (banking) and applied regenerative medicine treatments. Its core technology portfolio covers mesenchymal stem cell (MSC) therapy, exosome-based intercellular therapies, platelet-rich plasma (PRP), diamagnetic pain therapy (2.2 TESLA at 7Hz), and cell expansion services under controlled laboratory conditions. The company operates a Bogotá central laboratory with backup cryogenic storage at Vitalant in New Jersey, USA, and holds FDA registration (number 202) and FACT accreditation for cellular therapy standards.

The company's revenue model combines two streams: (i) subscription recurring revenue from stem cell collection, processing, cryopreservation and annual maintenance, and (ii) professional-services revenue from regenerative medicine treatments (MSC, exosome, PRP, diamagnetic, anti-aging) and B2B biobank services for physicians. Go-to-market is hybrid: enterprise channel partnerships with Colombian health insurance providers (EPS/ARS systems including Colmédica, Coomeva, Medplus, Compensar, Colsanitas, SOS), direct-to-consumer sales through website, phone, WhatsApp and social channels (LinkedIn, YouTube, Facebook, Instagram), event-driven engagement at international medical conferences, and medical tourism referrals for international patients (notably from USA and Spain).

America Cell Bank serves four primary customer segments: expectant parents seeking biological insurance via cord blood banking, adults seeking quality-of-life and anti-aging regenerative treatments, healthcare professionals and physicians using the ACB Biobanco channel, and international medical tourism patients. The company has physical offices in Colombia (HQ), USA (NJ), Ecuador, Spain (Madrid area), Peru, Venezuela, and the Dominican Republic, with service reach into Chile, Argentina and Mexico, and reports 15+ years of operational experience in regenerative medicine alongside 156+ Google reviews with strong Trustindex ratings.

Name

America Cell Bank

Legal name

America Cell Bank

Website

https://americacellbank.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Stem Cell Banking & Regenerative Medicine Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)

Keywords

• Stem cell banking
• Regenerative medicine
• Umbilical cord preservation
• Cellular therapy services
• Biological insurance services

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Stem Cell Banking Services: Collection, processing, cryopreservation and annual maintenance of umbilical cord blood and tissue stem cells for families. Covers registration, transfer, processing, cryopreservation and year of annual maintenance.
2. Regenerative Medicine Treatments: Clinical application of cellular therapies including mesenchymal stem cells, exosomes, PRP and combined protocols for various degenerative and musculoskeletal conditions.
3. Biobank Services: Biological product storage and management for clinical use with guaranteed quality and traceability, including processing, storage and subsequent transfer of samples.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

America Cell Bank collects, processes and cryopreserves umbilical cord blood and tissue stem cells for families, providing a form of biological insurance for future therapeutic use. The company also provides clinical regenerative medicine treatments using mesenchymal stem cells, exosomes, PRP and diamagnetic therapy for degenerative, musculoskeletal and chronic conditions. The ACB Biobanco service stores biological products (stem cells, exosomes) for clinical use with guaranteed quality and traceability.

Product overview

America Cell Bank operates as a multinational biomedical company offering an integrated 360° Global service portfolio centered around stem cell banking and regenerative medicine. The core offerings include: (1) Stem Cell Collection and Preservation – the flagship service for collecting and cryopreserving umbilical cord blood and tissue stem cells at birth, providing families with biological insurance for potential future therapeutic use; (2) Regenerative Medicine – personalized treatments using mesenchymal stem cells, exosomes, and complementary biological therapies addressing over 80 diseases including degenerative conditions, musculoskeletal injuries, autoimmune disorders, and neurological diseases; and (3) ACB Biobanco – specialized infrastructure for processing, storage, and long-term preservation of biological samples under international quality and traceability standards. The company also offers targeted sub-products including Pain Therapy combining diamagnetic techniques with stem cells, and Antiaging and Longevity protocols. All services are supported by international clinical protocols and an international network of specialized physicians.

Differentiator

Problem solved

Functional benefit

Products and services

• Stem Cell Collection and Preservation
• Regenerative Medicine Treatments
• ACB Biobanco (Biobank)
• Pain Therapy (Diamagnetic Therapy and Stem Cells)
• Antiaging and Longevity Protocols

Quantifiable outcome

• 1,000,000+ stem cell transplants performed worldwide supporting efficacy of stem cell therapies
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• VitalantcoreTechnology or IntegrationBackup bank partnership with Vitalant located in New Jersey, USA, ensuring that in the event of an adverse situation, all biological samples can be transferred to a suitable facility with best technology for continued preservation.
• SolamregcoreStrategic or Co-development PartnerStrategic alliance connecting scientific innovation with real clinical implementation. Organized IMMORTAL Summit 2026 combining online international participation with in-person workshop in Miami focused on hands-on training and advanced clinical application.
• ColmédicamajorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership for distribution of stem cell banking services to insured members.
• CoomevamajorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership including dedicated cord blood services through Cordon Coomeva brand for stem cell banking distribution.
• MedplusmajorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership for stem cell services distribution to members.
• CompensarmajorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership for regenerative medicine services distribution.
• ColsanitasmajorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership for stem cell banking services distribution.
• SOS (Servicio Occidental de Salud)minorChannel Partner/ Reseller/ DistributorHealth insurance provider partnership for patient services referrals.
• BestDoctorsminorChannel Partner/ Reseller/ DistributorMedical services company partnership for patient referrals and medical tourism.
• SEMALminorStrategic or Co-development PartnerResearch collaboration in biomedical projects and international scientific collaboration for regenerative medicine advancement.
• MAPFRE InsurancecoreOthersInsurance coverage provider ensuring liability protection for clinical operations and patient safety.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• StemCyte: StemCyte operates both private family banking and a sizable public cord blood inventory, with a therapeutic focus on cellular therapies. It is comparable to ACB on the combination of bank + downstream therapy positioning.
• Vita 34: Vita 34 is a leading European private cord blood bank headquartered in Germany serving families across Europe. It is comparable to ACB's Madrid-based European operations on the family banking subscription model.
• Cells4Life / Biovault Family: Cells4Life is a UK-based private cord blood and tissue bank with strong processing and storage infrastructure — a comparable family-banking subscription model and treatment-adjacent positioning.
• Cryo-Cell International: Cryo-Cell International is a U.S.-listed cord blood and tissue bank offering private family banking plus menstrual stem cell services. It is one of the closest direct competitors to ACB's core family cord-blood banking service in the Americas.
• ViaCord (PerkinElmer): ViaCord is a long-established U.S. family cord blood bank operated by Revvity (formerly PerkinElmer), offering collection, processing, and storage for newborns. It is directly comparable to ACB on subscription banking model and clinical-quality positioning.
• Cord Blood Registry (CBR) / Caladrius Biosciences affiliate: CBR is one of the largest U.S. family cord blood banks; comparable to ACB on subscription banking, sample processing infrastructure, and B2B OB/GYN channel relationships.

Emerging players

• Mesoblast: Mesoblast is a clinical-stage biotech commercializing mesenchymal stem cell therapies for inflammatory and degenerative diseases. It is comparable to ACB's MSC therapy line on modality and indications, though at a far larger scale and pharma-style commercialization model.
• Organa Bio: Organa Bio operates a perinatal tissue and cell banking platform (cord blood, cord tissue, placental tissue) with both storage and downstream therapeutic development — overlapping with ACB's cord blood and exosome product portfolio.
• HealthBanks Biotech: HealthBanks Biotech operates cord blood, adipose, and other tissue banking with multi-modality processing. It overlaps with ACB on the broader biobanking theme including stem-cell and regenerative applications.

Regional players

• CrioCord (Stemlab): CrioCord, part of the Stemlab group based in Portugal and active across Iberia, offers family cord blood and tissue banking in Europe — comparable to ACB's Spain operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@AmericaCellBank/videos
• Facebookfacebook.com/AmericaCellBankLatam
• LinkedInlinkedin.com/company/america-cell-bank
• Instagraminstagram.com/americacellbank
• Xx.com/AmericaCellBank

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about America Cell Bank